Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,431.40 22.86 0.14%
S&P 500 1,868.03 3.18 0.17%
NASDAQ 4,108.94 13.42 0.33%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,512.38 -3.89 -0.03%
TOPIX 1,171.40 -1.97 -0.17%
HANG SENG 22,760.24 64.23 0.28%

Horizon Pharma to Host an Investment Community Briefing on


Horizon Pharma to Host an Investment Community Briefing on RAYOS(R) on Monday, November 12, 2012

Live Webcast to Begin at 6:30 a.m. EST

DEERFIELD, IL -- (Marketwire) -- 10/29/12 -- Horizon Pharma, Inc. (NASDAQ: HZNP) announced today that it will host a live webcast to discuss the approval and initial launch of RAYOS(R) on Monday, November 12, 2012 at 6:30 a.m. Eastern Time. The webcast will be hosted by Timothy P. Walbert, chairman, president and chief executive officer of Horizon Pharma and will feature presentations from leading rheumatologists Maurizio Cutolo, M.D., of the University of Genova, Frank Buttgereit, M.D., of the Charite at the University of Berlin, and Arthur Weaver, M.D., of the University of Nebraska. The live webcast and a replay may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com.

About Horizon Pharma Horizon Pharma, Inc. is a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. For more information, please visit www.horizonpharma.com.

Contacts: Robert J. De Vaere Executive Vice President and Chief Financial Officer investor-relations@horizonpharma.com

Investors Kathy Galante Burns McClellan, Inc. 212-213-0006 kgalante@burnsmc.com

Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement